drugset / Trial / NCT04385199
Convalescent Plasma for Patients With COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
Pilot study of tolerability and efficacy of transfusion of 200mL of convalescent plasma in patients with COVID-19 respiratory disease.
Timeline
- Start
- 2020-05-04
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Convalescent Plasma | Protein / enzyme biologic | 200 ml | Other |